Exousia Bio, Inc. (LMMY): Cost of Revenue

Annual figures by period end, from SEC filings.

Partial revenue. In this company's filings, net income for the year ended 2025-05-31 is larger than reported revenue. The revenue it tags covers only part of its income (banks and REITs often tag only fee income this way, leaving out interest or rent), so it is not the company's whole top line. Margins on it are not computed, and it is left out of revenue rankings.